SmithKline Beecham: Clinical Trials

2 trials sponsored by SmithKline Beecham, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow SmithKline Beecham: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
Insulin, Glimepiride, Rosiglitazone - Type 2 Diabetes Mellitus
Phase 3CompletedVA Office of Research and Development17912000-12-012017-03-30
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
Albendazole - Protozoan Infections, HIV Infections
Phase 3CompletedSmithKline Beecham2005-06-24

Conditions studied

AIDS-Related Opportunistic Infections (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  HIV Infections (1)  ·  Insulin Resistance (1)  ·  Intestinal Diseases (1)  ·  Protozoan Infections (1)

Interventions

Albendazole (1)  ·  Insulin (1)  ·  Metformin (1)  ·  Rosiglitazone (1)  ·  glimepiride (1)

Countries

United States (2)  ·  Puerto Rico (1)

Top investigators

Carlos Abraira, MD (1)  ·  William Duckworth, MD (1)

Results publications

PMID 11347758, PMID 14583175, PMID 16043738, PMID 16504835, PMID 16627388, PMID 16784922, PMID 18406632, PMID 18671796, PMID 19092145, PMID 19655124, PMID 19720420, PMID 19726779, PMID 19898642, PMID 20807873, PMID 21059830, PMID 21775749, PMID 23536583, PMID 25048382, PMID 25456099, PMID 26039600, PMID 26786575, PMID 27006510, PMID 30455335, PMID 31167051, PMID 33367811